Compare VVX & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVX | TWST |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2014 | 2018 |
| Metric | VVX | TWST |
|---|---|---|
| Price | $55.15 | $29.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $64.40 | $46.33 |
| AVG Volume (30 Days) | 344.3K | ★ 1.9M |
| Earning Date | 11-03-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 791.53 | N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $4,419,142,000.00 | $376,572,000.00 |
| Revenue This Year | $4.18 | $17.89 |
| Revenue Next Year | $5.49 | $16.81 |
| P/E Ratio | $22.06 | ★ N/A |
| Revenue Growth | 5.10 | ★ 20.32 |
| 52 Week Low | $41.08 | $23.30 |
| 52 Week High | $63.74 | $55.33 |
| Indicator | VVX | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 49.37 |
| Support Level | $54.07 | $25.67 |
| Resistance Level | $55.59 | $31.80 |
| Average True Range (ATR) | 1.72 | 1.96 |
| MACD | 0.22 | 0.25 |
| Stochastic Oscillator | 68.74 | 71.98 |
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.